Pages that link to "Q34308674"
Jump to navigation
Jump to search
The following pages link to Whole-exome sequencing identifies ATRX mutation as a key molecular determinant in lower-grade glioma (Q34308674):
Displaying 50 items.
- Spinal cord tumours: advances in genetics and their implications for treatment (Q26851596) (← links)
- Oligodendroglioma: pathology, molecular mechanisms and markers (Q27002448) (← links)
- Telomere maintenance and the etiology of adult glioma (Q28084275) (← links)
- Genetic Inactivation of ATRX Leads to a Decrease in the Amount of Telomeric Cohesin and Level of Telomere Transcription in Human Glioma Cells (Q28118722) (← links)
- The somatic genomic landscape of glioblastoma (Q28300185) (← links)
- Molecular Markers in Low-Grade Glioma-Toward Tumor Reclassification (Q28383205) (← links)
- Decreased expression of the chromatin remodeler ATRX associates with melanoma progression (Q28385936) (← links)
- The epidemiology of glioma in adults: a "state of the science" review (Q28387839) (← links)
- Recursive partitioning analysis of prognostic variables in newly diagnosed anaplastic oligodendroglial tumors (Q30370204) (← links)
- The genetic landscape of anaplastic astrocytoma (Q33688888) (← links)
- ATRX mRNA expression combined with IDH1/2 mutational status and Ki-67 expression refines the molecular classification of astrocytic tumors: evidence from the whole transcriptome sequencing of 169 samples samples (Q33757037) (← links)
- Targetable signaling pathway mutations are associated with malignant phenotype in IDH-mutant gliomas. (Q33804713) (← links)
- Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy. (Q34342958) (← links)
- TERT promoter mutations in gliomas, genetic associations and clinico-pathological correlations (Q34499685) (← links)
- A Molecular Predictor Reassesses Classification of Human Grade II/III Gliomas (Q34785423) (← links)
- Whole-exome sequencing identifies somatic ATRX mutations in pheochromocytomas and paragangliomas (Q34998940) (← links)
- Clinicopathologic features of pediatric oligodendrogliomas: a series of 50 patients (Q35067733) (← links)
- The future of high-grade glioma: Where we are and where are we going (Q35114090) (← links)
- BRAF mutation and CDKN2A deletion define a clinically distinct subgroup of childhood secondary high-grade glioma (Q35168770) (← links)
- CHK1-driven histone H3.3 serine 31 phosphorylation is important for chromatin maintenance and cell survival in human ALT cancer cells (Q35171587) (← links)
- Protein domain-level landscape of cancer-type-specific somatic mutations (Q35203134) (← links)
- IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II-III diffuse gliomas (Q35204658) (← links)
- CDKN2A loss is associated with shortened overall survival in lower-grade (World Health Organization Grades II-III) astrocytomas (Q35418206) (← links)
- Massively parallel sequencing of phyllodes tumours of the breast reveals actionable mutations, and TERT promoter hotspot mutations and TERT gene amplification as likely drivers of progression (Q35911314) (← links)
- Clinical implementation of integrated whole-genome copy number and mutation profiling for glioblastoma (Q36082467) (← links)
- Isocitrate dehydrogenase mutations in gliomas (Q36367409) (← links)
- Co-expression of mitosis-regulating genes contributes to malignant progression and prognosis in oligodendrogliomas (Q36546013) (← links)
- IDH1/2 mutation status combined with Ki-67 labeling index defines distinct prognostic groups in glioma. (Q36557547) (← links)
- IDH mutation, 1p19q codeletion and ATRX loss in WHO grade II gliomas (Q36557573) (← links)
- Histone 3 lysine 9 trimethylation is differentially associated with isocitrate dehydrogenase mutations in oligodendrogliomas and high-grade astrocytomas (Q36737930) (← links)
- Mutations in SETD2 and genes affecting histone H3K36 methylation target hemispheric high-grade gliomas (Q36780903) (← links)
- What do we know about IDH1/2 mutations so far, and how do we use it? (Q36788229) (← links)
- Atrx deficiency induces telomere dysfunction, endocrine defects, and reduced life span. (Q36793436) (← links)
- Accumulation of 2-hydroxyglutarate is not a biomarker for malignant progression in IDH-mutated low-grade gliomas (Q36865995) (← links)
- Loss of ATRX and DAXX expression identifies poor prognosis for smooth muscle tumours of uncertain malignant potential and early stage uterine leiomyosarcoma (Q36873846) (← links)
- Evaluation of histone 3 lysine 27 trimethylation (H3K27me3) and enhancer of Zest 2 (EZH2) in pediatric glial and glioneuronal tumors shows decreased H3K27me3 in H3F3A K27M mutant glioblastomas (Q36981245) (← links)
- Is glioblastoma an epigenetic malignancy? (Q37226526) (← links)
- Clinical value of chromosome arms 19q and 11p losses in low-grade gliomas (Q37580501) (← links)
- Deep targeted sequencing in pediatric acute lymphoblastic leukemia unveils distinct mutational patterns between genetic subtypes and novel relapse-associated genes (Q37665574) (← links)
- Chromatin remodeling defects in pediatric and young adult glioblastoma: a tale of a variant histone 3 tail (Q38083799) (← links)
- Pediatric high-grade astrocytomas: a distinct neuro-oncological paradigm (Q38125816) (← links)
- The molecular landscape of diffuse glioma and prospects for biomarker development (Q38155656) (← links)
- Where are we now? And where are we going? A report from the Accelerate Brain Cancer Cure (ABC2) low-grade glioma research workshop. (Q38168686) (← links)
- Prognostic and predictive biomarkers in adult and pediatric gliomas: toward personalized treatment (Q38203283) (← links)
- Isocitrate dehydrogenase 1 and 2 mutations in gliomas. (Q38235572) (← links)
- Refining the role for adult stem cells as cancer cells of origin (Q38252977) (← links)
- The evolving molecular genetics of low-grade glioma (Q38349169) (← links)
- The Emerging Molecular Foundations of Pediatric Brain Tumors (Q38421001) (← links)
- Diagnostic, prognostic and predictive relevance of molecular markers in gliomas (Q38461565) (← links)
- Diffusely infiltrating astrocytomas: pathology, molecular mechanisms and markers (Q38480437) (← links)